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Edited by Takashi GojoboriAbstract Chicken muscular dystrophy with abnormal muscle
(AM) has been studied for more than 50 years, but the gene
responsible for it remains unclear. Our previous studies narrowed
down the AM candidate region to approximately 1 Mbp of
chicken chromosome 2q containing seven genes. In this study,
we performed sequence comparison and gene expression analysis
to elucidate the responsible gene. One missense mutation was de-
tected in AM candidate genes, while no remarkable alteration of
expression patterns was observed. The mutation was identiﬁed in
WWP1, detected only in dystrophic chickens within several tet-
rapods. These results suggested WWP1 is responsible for chick-
en muscular dystrophy.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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gene1. Introduction
Muscular dystrophy is known as a group of inherited dis-
eases producing progressive weakness and degeneration of
skeletal muscles [1]. Many genetically varied diseases are in-
cluded, and more than 30 causative genes have been identiﬁed
so far [2]. However, genes responsible for several muscular dys-
trophies and related diseases have not yet been identiﬁed [3].
Asmundson and Julian have ﬁrst reported dystrophic chick-
ens with abnormal muscle (AM) in 1956 [4]. Since then, several
strains have been established. The disease is transmitted co-
dominantly by a single gene, but the phenotype is modiﬁed
by other background genes [5–7]. Although abnormalities in
the structural proteins binding sarcolemma to basal lamina
were found in many animal models for muscular dystrophyAbbreviations: AM, abnormal muscle; UPP, ubiquitin-proteasome
pathway; Ub, ubiquitin
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doi:10.1016/j.febslet.2008.05.013[8], the responsible gene(s) and protein(s) responsible for caus-
ing chicken muscular dystrophy have yet to be identiﬁed. This
study attempted to identify the responsible gene and mutation
by sequence comparison and expression analysis.2. Materials and methods
2.1. Genetic resource
For sequencing and expression analyses, NH-413 and OPN strains
were tested as dystrophic chickens [9], and White Leghorn-F (WL-F)
and GSP strains were as normal chickens.
Genomic DNA samples were obtained from total 111 individuals
consisting of 16 strains: 20 White Cornishes, 19 White Plymouth
Rocks, 20 broilers (White Cornish ·White Plymouth Rock), 20 White
Leghorns, and 20 Brown Leghorns, maintained at the Tokushima For-
est and Forestry Research Institute, Japan, an Onagadori, an Ukokkei,
a White Leghorn, a White Plymouth Rock, a Black Minorca, a Fayo-
umi, a Vietnam native, a Laos native, an Echigo native, a Tosa native,
and two Red Jungle fowls from Laos and Indonesia. Muscle cDNA li-
braries of pigeon, alligator, lizard, turtle and frog, and liver cDNA li-
brary of snake, were used to determine partial sequences of WWP1
gene in this study [10,11].
2.2. Sequencing for seven candidate genes
Pectoral muscle cDNAs were used as template DNA to sequence for
WWP1, LOC420213, LOC420214 and MMP16, while genomic DNA
for ATP6V0D2, LOC420211 and LOC428367. In using cDNA as tem-
plate, primers were designed to amplify each coding region, and in
using genomic DNA, to amplify each exon. The primer sequences
and the PCR conditions were summarized in Table 1(a). Sequencing
was performed with BigDye Terminator v3.1 Cycle Sequencing Kit
and ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster
City, CA). For polymerase chain reaction (PCR), TaKaRa Ex Taq
Hot Start Version or TaKaRa LA Taq with GC buﬀer (Takara, To-
kyo, Japan) was used as polymerase.
2.3. Genotyping chickens for WWP1
Genotyping of 111 individuals from 16 strains for WWP1 was car-
ried out by PCR-restriction fragment length polymorphism (RFLP)
method. Primer set was established to amplify the region with a single
nucleotide polymorphism (SNP) on WWP1. One of them was mis-
matched primer and designed so that the chicken with wild-type
WWP1 yielded three DNA fragments and the one with mutated
WWP1 yielded two through digestion by a MboI restricted enzyme
(Fermentas International Inc., Ontario, Canada). The primer se-
quences and the PCR condition applied were shown in Table 1(b).blished by Elsevier B.V. All rights reserved.
Table 1
Sequences of primers and PCR conditions for sequencing, genotyping and expression analysis
Name Primera Sequence (50 ﬁ 30) PCR conditionb
(a) Primers used for sequencing to produce template DNA
ATP6V0D2 ATP6V0D2s-F1 tctaaaactatgtgagcctggagtag Normal PCR (EX-Taq): 58 C
ATP6V0D2s-R1 ccaaatcacagtctacacaatcctgc 1 min, 30 cycles
ATP6V0D2s-F2 gacacgttataatggtgcaatagtgg Normal PCR (EX-Taq): 58 C
ATP6V0D2s-R2 ccagaccctatacacagtaaagagtc 1 min, 30 cycles
ATP6V0D2s-F3 gagatggtgatagtgagtgaaggtac Normal PCR (EX-Taq): 58 C
ATP6V0D2s-R3 tagaagttgttaataaatgttgccag 1 min, 30 cycles
ATP6V0D2s-F4 gctgctgcactgattgattccctttg Normal PCR (EX-Taq): 64 C
ATP6V0D2s-R4 tccagacttgccatcagccaggtgac 1 min, 30 cycles
ATP6V0D2s-F5 attatgcagtagaaactcaatggagc Normal PCR (EX-Taq): 58 C
ATP6V0D2s-R5 aaaatggtaaggagcaatagtctgag 1 min, 30 cycles
ATP6V0D2s-F6 aagtacgtgtgattattgatccttac Normal PCR (EX-Taq): 58 C
ATP6V0D2s-R6 atagcatttaacacagtaagtggaac 1 min, 30 cycles
ATP6V0D2s-F7 gaagttcagtgctctctatccaaagg Normal PCR (EX-Taq): 58 C
ATP6V0D2s-R7 ttggtaagagactacagcagcattac 1 min, 30 cycles
ATP6V0D2s-F8 agtttcctaagtacagttgtgattgc Normal PCR (EX-Taq): 58 C
ATP6V0D2s-R8 catttaacttcagcaacaggtcacag 1 min, 30 cycles
LOC420211 LOC420211s-F ctgaaggagtccacacgcccaagtca SH PCR (LA-Taq): 68 C
LOC420211s-R cgagcaacagaactagcagacattcc 3 min, 27 cycles
WWP1 WWP1s-F1 aggctccacatgggcagaactttgtc Normal PCR (EX-Taq): 62 C
WWP1s-R1 tcaaataggcagtacatagggttcag 2 min, 35 cycles
WWP1s-F2 acttgctcatttccgttacttgtgtc Normal PCR (EX-Taq): 65 C
WWP1s-R2 ttgaagattacctaacatcctcgtgg 2 min, 30 cycles
LOC420213 LOC420213s-F ctcgctcgcaccttctcctcccctgg SH PCR (EX-Taq): 68 C
LOC420213s-R ttcattttcctatgctgcttacatct 1 min, 40 cycles
LOC420214 LOC420214s-F atggcagcacagtgtgtgactaaggt SH PCR (EX-Taq): 68 C
LOC420214s-R atccccgctcaagaaagtaactgatc 2 min, 32 cycles
LOC428367 LOC428367s-F1 gggaagtgaaggcaagagcaccaggc Normal PCR (EX-Taq): 64 C
LOC428367s-R1 gaggagatttagattagatgttagca 1 min, 30 cycles
LOC428367s-F2 ctgctacagtattcccagtgagagat Normal PCR (EX-Taq): 55 C
LOC428367s-R2 gatgagatataaatgtggtacaagta 1 min, 30 cycles
LOC428367s-F3 atcattctcagcaataaccatctagt Normal PCR (EX-Taq): 55 C
LOC428367s-R3 tttcagataatcttggagcactcata 1 min, 30 cycles
LOC428367s-F4 tgaagagataatggaagccaagttct SH PCR (EX-Taq): 68 C
LOC428367s-R4 tgaatactgggtaaatgtggttgcct 2 min, 32 cycles
LOC428367s-F5 taatgcttgacttctgcttgtactat Normal PCR (EX-Taq): 55 C
LOC428367s-R5 atgagtaaatgtgatgtggtaagata 1 min, 30 cycles
LOC428367s-F6 gaaggttcccaaatactccattaaca Normal PCR (EX-Taq): 55 C
LOC428367s-R6 gaaaacatataatctcacaatctgta 1 min, 30 cycles
LOC428367s-F7 atactgtttcttcactggagtaatga Normal PCR (EX-Taq): 60 C
LOC428367s-R7 catatgtacttgagcaggtcagttga 1 min, 30 cycles
LOC428367s-F8 tcacagagtaaatacaggtggagagc Normal PCR (EX-Taq): 60 C
LOC428367s-R8 ctgccatccttctaacagttcccat 1 min, 30 cycles
LOC428367s-F9 gtcagtgaggatattctgttcaatgt Normal PCR (EX-Taq): 55 C
LOC428367s-R9 agataaatactcagttttctggttaa 1 min, 30 cycles
LOC428367s-F10 tacagactgtttcttacacaaccagc Normal PCR (EX-Taq): 60 C
LOC428367s-R10 tcactgattacttaactgcttctgaa 1 min, 30 cycles
(continued on next page)
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Table 1 (continued)
Name Primera Sequence (50 ﬁ 30) PCR conditionb
LOC428367s-F11 tcagtggagtatcaacttcagagatt Normal PCR (EX-Taq): 55 C
LOC428367s-R11 aagcacctatatgtactagcagacaa 1 min, 35 cycles
LOC428367 LOC428367s-F12 gttgtcaggtgttcatccacacattc Normal PCR (EX-Taq): 55 C
LOC428367s-R12 ctatttctctatccatcatcctctac 1 min, 35 cycles
LOC428367s-F13 tgcttcttggttgatctatgctctcc Normal PCR (EX-Taq): 55 C
LOC428367s-R13 ggttttattctgtagccgtctctcct 1 min, 35 cycles
MMP16 MMP16s-F tgaacctgcgttacgggctcctcac SH PCR (EX-Taq): 68 C
MMP16s-R ccttgtttgttggaaaatggctgtc 2.5 min, 35 cycles
(b) Primers used for genotyping
WWP1 WWP1m-F agagaaaatgagctatgcagtattac Normal-PCR (EX-Taq): 56 C
WWP1m-R-mismatch tatataaaatttaccgaatagagggaa 1 min, 35 cycles
(c) Primers used for identifying WWP1 partial sequence of other species
WWP1 WWP1d-F1 aacaacvtggcagcgrccwachatgg DG-PCR (EX-Taq)
WWP1d-R gtaavccttgrgttckwggrtcttc
WWP1d-F2 aaytttgarcagtggcartctcagc DG-PCR (EX-Taq)
WWP1d-R gtaavccttgrgttckwggrtcttc
(d) Primers used for expression analysis
ATP6V0D2c ATP6V0D2p-F atattgtatggattgccgaatgc Normal-PCR (EX-Taq): 60 C
ATP6V0D2p-R cgaaatggtcactgtggggaaca 0.5 min, 25, 30, 35 cycles
LOC420211c LOC420211p-F aaaggactgaataccatctgatt Normal-PCR (EX-Taq): 55 C
LOC420211p-R tacaactgctaaatgctccctca 0.5 min, 25, 30, 35 cycles
WWP1 WWP1p-F tccctcataaatgttgaaagcagaca Normal-PCR (EX-Taq): 55 C
WWP1p-R gtaataacccaaggtaatatgtaaac 0.5 min, 35 cycles
LOC420213 LOC420213p-F agtggcagaagttatagagcaagcag Normal-PCR (EX-Taq): 60 C
LOC420213p-R cgtgtatgtcttctcctgtttgtcca 0.5 min, 35 cycles
LOC420214 LOC420214p-F tggtatgaggttgatcgcacagaaag Normal-PCR (EX-Taq): 60 C
LOC420214p-R ggtgctacagttttgacttccttcgt 0.5 min, 35 cycles
LOC428367d LOC428367p-F tgtcttcgtcttctccagcttaattg –
LOC428367p-R ggctaataggctgatctccccaaata
MMP16c MMP16p-F cataatctttcccaagttgtaccaag Normal-PCR (EX-Taq): 52 C
MMP16p-R gcaatatcagagtcatcattttagtt 0.5 min, 25, 30, 35 cycles
aEach columns upper primers are forward primers and lower ones reverse primers.
bEach column shows PCR method (polymerase): annealing temperature, extension time, cyclic number applied by each primer sets. Normal PCR was
performed as the following: cyclic number at 94 C for 30 s, annealing temperature for 30 s, 72 C for extension time, SH PCR: cyclic number at
98 C for 10 s, 68 C for extension time, and DG PCR: 3 cycles at 95 C for 30 s, 50 C for 30 s, 72 C for 30 s and 32 cycles at 95 C for 30 s, 50 C
for 30 s, 72 C for 30 s.
cTo analyze their expressions, RT-PCR was performed.
dExpression of this gene was not conﬁrmed.
2214 H. Matsumoto et al. / FEBS Letters 582 (2008) 2212–22182.4. WWP1 homology search among species
To obtain WWP1 partial sequences of pigeon, snake, alligator, liz-
ard, turtle and frog, degenerate primers were designed based on those
of chicken (NM_001012554), human (NM_007013), mouse (NM_
177327) and rat (NM_001024757) published in NCBI. To amplify each
WWP1 of snake, alligator and pigeon, WWP1d-F1 and WWP1d-R
were used as primers, and WWP1d-F2 and WWP1d-R were used for
other species. The primer sequences and the PCR condition were
shown in Table 1(c). The ampliﬁed bands corresponding to WWP1
cDNAs were extracted from agarose gel and puriﬁed with Ultra-
Clean 15 DNA Puriﬁcation Kit (MO BIO Laboratories Inc., Carls-
bad, CA). The puriﬁed cDNA fragments were ligated into pGEM-Tvectors (Promega Corporation, Madison, WI) and transformed into
Escherichia coli JM109 competent cells. To conﬁrm the sequence integ-
rity, eight independent clones were sequenced.2.5. Expression analysis
For Northern blot analysis, pectorals mRNAs of a NH-413 and a
WL-F strain female were used. 2 lg of mRNAs were resolved by
1.2% agarose gel electrophoresis in the presence of formaldehyde
and blotted on to Hybond-N+ membrane (GE Healthcare Bio-Sci-
ences AB, Uppsala, Sweden). The mRNAs were visualized using
digoxigenin (DIG) reagents (Roche Diagnostics, Basel, Switzerland).
H. Matsumoto et al. / FEBS Letters 582 (2008) 2212–2218 2215The DIG-labeled DNA probes were prepared by PCR with DIG-
dUTP using pectorals cDNA. The primers used in this procedure were
shown in Table 1(d).
For genes whose expression was not detected by Northern blotting,
reverse transcription (RT)-PCR method was applied with same condi-
tion in Table 1(d).3. Result
3.1. Mutations speciﬁc to muscular dystrophy
Sequence comparison of seven candidate genes in normal
and dystrophic chickens revealed three synonymous mutations
and one missense mutation speciﬁc to the phenotype of muscu-
lar dystrophy. Two of the synonymous mutations were de-
tected in LOC420214 (C660T and C1009A), and the other in
LOC428367 (C954T). The WWP1 missense mutation
(G1321A) caused amino acid substitution from arginine to glu-
tamine, leading to the molecular alteration from a basic side
chain to an uncharged polar side chain. We focused further
studies on this missense mutation since it was predicted to
inﬂuence the function of the WWP1 protein.
The domain structure of human WWP1 was determined pre-
viously [12]. It consists of three types of unique domains: one
C2 domain, four WW domains and one HECT domain. The
amino acid sequences of human and chicken WWP1 share
83% identity, suggesting that the deduced structure of chicken
WWP1 was quite similar to that of humans. According toFig. 2. Homology study ofWWP1 among tetrapods. Chicken N and A show
R441Q WWP1 mutation is speciﬁc to chicken muscular dystrophy, and the am
Dots indicate the same amino acids with above sequences. Asterisk indicates
Amino acid sequence published in NCBI.
Fig. 1. The domain structure of chicken WWP1 and the site of
missense mutation. Chicken WWP1 protein is composed of 922 amino
acids. Here are shown WWP1 functional domains: C2 domain, three
WW domains and HECT domain. C in HECT domain indicates an
active cysteine residue. The arrow indicates the site of missense
mutation detected in this study. WW domains bind proline-rich region.NCBI database, chicken WWP1 possesses one C2 domain,
three WW domains and one HECT domain. The detected
mutation lay between WW domains 1 and 2 (Fig. 1).
3.2. Intra- and inter-species analyses of R441QWWP1 mutation
In order to exclude the possibility of strain speciﬁcity of
WWP1 mutation, this SNP was genotyped in OPN strain to
determine if the WWP1 gene has this mutation in any strain
with a diﬀerent genetic background. PCR-RFLP analysis indi-
cated that OPN dystrophic chickens have the identical muta-
tion in the WWP1 gene. Genotyping was also applied to 111
normal birds from 16 strains with genetically varied back-
grounds. None of the normal birds exhibited this type of sub-
stitution. The region of WWP1 including the SNP speciﬁc to
chicken muscular dystrophy was highly conserved among nor-
mal birds. Additional homology research among tetrapods was
conducted to estimate amino acid conservation in this region.
The sequences of chicken, human, chimpanzee (XP_519843),
monkey (XP_001083173), mouse, rat, dog (XP_535119) and
cattle (NP_001032540) were available in the NCBI database.
To obtain further information from other tetrapod species,
we sequenced partial WWP1 gene of pigeon, snake, alligator,
lizard, turtle and frog (DDBJ Accession Nos. AB385863 to
AB385868). The amino acid sequence around the region was
highly conserved among these tetrapods (Fig. 2), suggesting
that the region was important for the function of WWP1.
3.3. Expression analysis of candidate genes
Expressions of candidate genes were analyzed by Northern
blotting. As depicted in Fig. 3a, the expression of WWP1,
LOC420213 and LOC420214 in the pectoral muscle of both
genotypes derived from both normal and dystrophic chicken
could be detected by Northern blotting. There was no diﬀer-
ence in size of mRNA between aﬀected and normal birds in
any of these genes.LOC420213 was highly expressed in aﬀected
individuals. Two bands were detected in WWP1 and
LOC420214. WWP1 was expressed slightly higher in normal
than in aﬀected chickens, while a slightly higher level of expres-
sion was exhibited for LOC420214 from aﬀected chickens.amino acid sequences of normal and dystrophic chickens, respectively.
ino acid sequence on this region is highly conserved among tetrapods.
the residue that the substitution was detected in dystrophic chicken. (1)
Fig. 3. Expression analysis of candidate genes. Extreme alteration of expression level was not observed in any genes. (a) Northern blotting analysis
toward ATP6V0D2, LOC420211, WWP1, LOC420213, LOC420214, MMP16 using chicken pectoral mRNA (2 lg). In any of these genes, there was
no diﬀerence in size of mRNA between aﬀected and normal birds. The C indicates loaded PCR product which has the same sequence as probe, the A
indicates mRNA of dystrophic chickens and the N indicates mRNA of normal chickens, respectively. The arrows indicate the band detected. b) RT-
PCR analysis toward ATP6V0D2, LOC420211, MMP16 using chicken pectoral cDNA.
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LOC420211 and LOC428367) was not detected by Northern
blotting. RT-PCR analysis in dystrophic chickens revealed
higher expression of ATP6V0D2 and MMP16 than in normal
birds. The pectoral muscles from both genotypes expressed
LOC420211 to identical level. The expression of LOC428367-
was not conﬁrmed in either genotype.4. Discussion
We previously narrowed down the AM candidate region to
approximately 1 Mbp on GGA2q. Seven functional genes,
ATP6V0D2, LOC420211, WWP1, LOC420213, LOC420214,
LOC428367 and MMP16, in this region were the candidate
genes for chicken muscular dystrophy [13,14], but none of
them have been determined to be genes for other muscular dys-
trophy so far. In this study, sequence comparison of normal
and dystrophic chickens was conducted to detect a mutation
responsible for the disease.We detected a mutation site speciﬁc for the AM phenotype
in G1321A of theWWP1 gene that caused amino acid replace-
ment, from arginine with a basic side chain (a basic amino
acid) to glutamine with an uncharged polar side chain (a neu-
tral amino acid), which can aﬀect the function of the WWP1
protein. WWP1 mutated in the coding region of the protein,
providing the most likely candidate responsible for causing this
disease. This type of mutation was only observed in dystrophic
chickens. No mutation was detected in any normal chickens
analyzed. Furthermore, the amino acid sequence on this region
is highly conserved among tetrapods (Fig. 2). The region is
thus probably critical for the function of WWP1.
The expression patterns of the candidate genes were analyzed
in Fig. 3.WWP1,LOC420213,ATP6V0D2 andMMP16 exhib-
ited some diﬀerence in expression level between normal and dys-
trophic individuals, none of which were drastic alterations. No
diﬀerence in mRNA size was observed in any gene. Since no ex-
treme alteration of expression level and abnormal splicing were
observed, the onset of chicken muscular dystrophymight not be
attributed to aberrant expression of these genes.
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(WWP1), the most likely AM candidate gene found by this
study, is classiﬁed as an ubiquitin ligase (E3) that plays an
important role in ubiquitin-proteasome pathway (UPP). Ubiq-
uitination, addition of ubiquitin (Ub) chains to a target pro-
tein, is one of the most common forms of posttranslational
modiﬁcation, and it controls important aspects of cell func-
tions [15,16]. In UPP, at least three types of enzymes are re-
quired, namely, E1 Ub-activating enzyme, E2 Ub-
conjugating enzyme and E3 [17]. E3 recognizes and catalyzes
Ub conjugation to speciﬁc protein substrates [18]. E3s are
structurally divided into several classes: HECT-type E3s,
RING-type E3s and others [19].
Accumulating data indicate that some E3s are related to
muscular dystrophies [20–22]. E3s that are assumed to be re-
lated to muscular dystrophies, such as Trim32 [25], are all clas-
siﬁed as RING-type E3s, whileWWP1 is classiﬁed as a HECT-
type E3. RING-type E3s facilitate ubiquitination indirectly,
while HECT-type E3s transfer Ub directly to substrates bound
to a non-catalytic domain of themselves [23]. Though they are
structurally and mechanically distinct, their basic role in UPP
is common. Therefore, it is possible for some abnormal
HECT-type E3s to cause muscular dystrophies. Actually, it
has been reported that E6AP, another HECT-type E3, contrib-
utes to a severe neurological disorder, Angelman syndrome
[24,25] which exhibits muscular hypotonia [26].
WWP1 is expressed ubiquitously but more strongly in liver,
bone marrow, testis, and muscle [12]. Flasza et al. also men-
tioned at least six splice variants of WWP1 [12]. Two of the
six products are commonly observed among multiple tissues,
and their expression levels are higher than the others. The
bands detected by Northern blotting (Fig. 3a) may correspond
to these two major products, but little is known about the
function of these transcript variants.
E6AP is known as the gene responsible for Angelman syn-
drome [24]. Cooper et al. reported that two mutations lying
in the non-catalytic amino-terminal portion of E6AP cause
Angelman syndrome [25]: one of them aﬀects E6AP enzymatic
activity, and the other may disturb substrate binding, subcellu-
lar localization or protein stability. The mutation of WWP1
detected in this study is located between WW domains 1 and
2 (Fig. 1). Though the mutation is outside all domains, it is
predicted that the region near the mutation is functionally
important because of its high homology (Fig. 2). The R441Q
mutation probably inﬂuences the WWP1 function like Angel-
man syndrome causative mutations, so that it triggers the on-
set. Since the mutation lies between two domains both of
which recognize target proteins [27], it could alter the confor-
mation of WWP1 [28], the physical relationship among do-
mains and the preference for substrates.
Aberrant regulation of membrane protein may lead to the
onset of chicken muscular dystrophy. The HECT-type E3s
with WW domains generally regulate membrane proteins
[29]. Though much remains unclear about WWP1s substrates,
it has been demonstrated that WWP1 could interact with b-
dystroglycan, an important muscle protein consisting of
membrane [30]. Abnormal glycosylation of a-dystroglycan in
chicken muscular dystrophy was also reported [31]. Some
E3s are known to recognize sugar chain [32–34], leading to
the hypothesis that WWP1 might be able to recognize the su-
gar chain of a-dystroglycan and regulate the glycosylated mol-
ecules, and that insuﬃciently glycosylated a-dystroglycan,which originally requires degradation, accumulates and causes
the disease because altered WWP1 can not recognize and
degrade it.
This study identiﬁed R441Q WWP1 mutation as being spe-
ciﬁc to chicken muscular dystrophy. This is the most likely
candidate mutation responsible for chicken muscular dystro-
phy because the region nearby is highly conserved among spe-
cies and no drastic alteration of expression patterns of the
candidate genes was observed. In order to clarify the mecha-
nism by which mutated WWP1 triggers the onset of chicken
muscular dystrophy, further biochemical research is required.
The information must be useful for determining the corre-
sponding human dystrophy and for providing new insights
for understanding muscular dystrophies.
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